Tilray is a global leader in medical cannabis production and research dedicated to providing safe, consistent and reliable therapy to patients. Our flagship facility in Nanaimo, B.C., is GMP-certified, producing medical cannabis in whole flower, cannabis oil and capsules to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in Australia, Canada, the European Union and the Americas.
In Canada, Tilray supports clinical trials focused on pediatric epilepsy at SickKids Hospital, post-traumatic stress disorder at the University of British Columbia, and chronic obstructive pulmonary disease at McGill University Health Centre. In Australia, Tilray has partnered with the University of Sydney and New South Wales Government to study medical cannabis as a treatment for symptoms of chemotherapy-induced nausea and vomiting. We plan to announce additional research partnerships in the new year.
We are committed to helping patients by providing excellent customer service. Our bilingual Patient Services team is available 24/7 to provide information and answer questions on Tilray products. Our national network of clinic partnerships helps connect patients and health-care providers with the latest information and research. Tilray. Improving lives through medical cannabis.
Please note that Tilray does not authorize, engage, or sponsor any consultants, agencies or organizations that seek certain personal or financial information from you (e.g. passwords, login ids, credit card information). Tilray does not charge any application, processing or onboarding fee at any stage of the recruitment or hiring process.
When replying to emails, please ensure the sender name and email address match exactly. Please also ensure the Reply-To address matches the sending address exactly.
If you are concerned about the authenticity of an email, letter, or call purportedly from, for, or on behalf of Tilray, please send an email inquiry to firstname.lastname@example.org.